Latest News

  • INVESTMENT

    12 Jan 2026

    Lilly’s Ventyx Deal Points to a Future Beyond Injections

  • MARKET TRENDS

    8 Jan 2026

    Oral Weight Loss Pills Are Shaking Up Metabolic Care

  • PARTNERSHIPS

    6 Jan 2026

    Pfizer’s Metsera Deal Ignites a New Obesity Drug Arms Race

  • RESEARCH

    19 Dec 2025

    Liver-First Drugs Redefine the Next Phase of the MASH Race

FDA Pilot Voucher Signals Faster Reviews for Metabolic Drugs

Business discussion reflecting FDA pilot voucher accelerating metabolic drug reviews

REGULATORY

18 Dec 2025

A new FDA pilot voucher could shrink review timelines for select obesity and diabetes drugs, stirring optimism and debate across the sector

Aardvark Therapeutics logo featuring stylized A and molecular design.

INSIGHTS

8 Dec 2025

The Oral Bet Challenging Today’s GLP 1 Era

Aardvark and Rivus advance early stage metabolic therapies as interest grows beyond GLP 1 drugs and potential new options emerge

Orforglipron pill bottle beside scale and measuring tape for metabolic treatment research

RESEARCH

5 Dec 2025

Oral Obesity Drug Fuels Competition in Metabolic Care

Lilly’s oral orforglipron heats up the race to reshape obesity and diabetes treatment

FDA approved sign displayed on laptop and documents during regulatory review.

REGULATORY

4 Dec 2025

FDA Draft Sparks a Metabolic Shake Up

New FDA guidance pushes durability to the forefront as industry giants deepen their metabolic bets

Blue Excelsior Sciences logo featuring arrow loop icon on a white background.

INNOVATION

3 Dec 2025

AI Tools Stir Cautious Shift in US Metabolic Innovation Race

Firms explore AI to speed discovery as analysts note opportunity, uncertainty and a fluid competitive landscape

Logo of the Coalition for Metabolic Health displayed over imagery of nutritional and health-related elements

PARTNERSHIPS

2 Dec 2025

Metabolic Care Gets a National Wake Up Call

New US metabolic alliance pushes earlier care and integrated treatments; firms like Lilly and Novo Nordisk should prepare for shifting sta...

Bathroom scale with measuring tape on tiled floor symbolising weight management

INVESTMENT

1 Dec 2025

A MASH Contender Puts Roche in the Spotlight

Roche’s move to acquire 89bio boosts a leading MASH therapy and opens new partnership opportunities across metabolic medicine

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.